Anait L. Melikyan

190 Rodionova St
Velikiy Novgorod, NGR 603126, Russian Federation

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 24 publications

Multicenter Single-Blind Randomized Controlled Trial of the Romiplostim Biosimilar.

Multicenter Single-Blind Randomized Controlled Trial of the Romiplostim Biosimilar.

Journal: EJHaem

Published: February 03, 2025

Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia.

Optimization of Romiplostim Biosimilar Efficacy Trial Using In Silico Clinical Trial Approach for Patients With Immune Thrombocytopenia.

Journal: Clinical pharmacology in drug development

Published: July 06, 2024

Active spread of β-thalassemia beyond the thalassemia belt: A study on a Russian population.

Active spread of β-thalassemia beyond the thalassemia belt: A study on a Russian population.

Journal: Clinical genetics

Published: June 24, 2024

Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial.

Sustained response off-treatment in eltrombopag-treated adult patients with ITP who are refractory or relapsed after first-line steroids: Primary, final, and ad-hoc analyses of the Phase II TAPER trial.

Journal: American journal of hematology

Published: December 06, 2022

Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report

Repeated haploidentical allogeneic hematopoietic stem cell transplantation with TCR αβ/CD19 depletion in patient with primary myelofibrosis. Case report

Journal: Terapevticheskii arkhiv

Published: July 20, 2021

Thrombosis in patients with myeloproliferative neoplasms. Case report

Thrombosis in patients with myeloproliferative neoplasms. Case report

Journal: Terapevticheskii arkhiv

Published: July 20, 2021

Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations.

Low JAK2 V617F Allele Burden in Ph-Negative Chronic Myeloproliferative Neoplasms Is Associated with Additional CALR or MPL Gene Mutations.

Journal: Genes

Published: February 19, 2021

The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description

The prognostic value of ASXL1 mutation in primary myelofibrosis. Literature review and clinical case description

Journal: Terapevticheskii arkhiv

Published: August 26, 2020

Brain MRI-findings in Ph - negative myeloproliferative disorders

Brain MRI-findings in Ph - negative myeloproliferative disorders

Journal: Terapevticheskii arkhiv

Published: April 16, 2020

Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome

Clinical features and diagnosis of Ph - negative myeloproliferative neoplasms occurring in conjunction with the antiphospholipid syndrome

Journal: Terapevticheskii arkhiv

Published: April 16, 2020

Postoperative Hypoparathyroidism: Prognosis, Prevention, and Treatment (Review).

Postoperative Hypoparathyroidism: Prognosis, Prevention, and Treatment (Review).

Journal: Sovremennye tekhnologii v meditsine

Published: April 04, 2019

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.

Cepeginterferon alfa-2b in the treatment of chronic myeloproliferative diseases.

Journal: Terapevticheskii arkhiv

Published: February 01, 2019

Showing 1-12 of 24

Last Updated: 09/26/2026